Breaking News - The Fly

Open Search

ELDN

Eledon Pharmaceuticals

$

()

Eledon Pharmaceuticals reports Q4 EPS (32c), consensus (39c)

ELDN

3/28/2024 - 16:04pm

Eledon announces use of tegoprubart in transplant of genetically modified kidney

ELDN

3/21/2024 - 10:35am

Eledon Pharmaceuticals announces anticipated 2024 milestones

ELDN

1/4/2024 - 16:46pm

Eledon Pharmaceuticals reports Q3 EPS (35c), consensus (50c)

ELDN

11/9/2023 - 16:16pm

Eledon Pharmaceuticals reports updated data from Phase 1b trial of tegoprubart

ELDN

11/2/2023 - 09:22am

Eledon Pharmaceuticals price target lowered to $13 from $25 at H.C. Wainwright

ELDN

10/24/2023 - 06:13am

Eledon Pharmaceuticals appoints Katz as CMO

ELDN

10/23/2023 - 07:10am

Eledon Pharmaceuticals appoints Kirk to board of directors

ELDN

10/2/2023 - 07:09am

Eledon Pharmaceuticals initiated with an Outperform at Noble Capital

ELDN

9/27/2023 - 07:40am

Eledon:Tegoprubart used as part of imunosuppressive regimen post transplant

ELDN

9/25/2023 - 07:06am

Eledon Pharmaceuticals appoints Robinson to board of directors

ELDN , DNPUF

9/11/2023 - 07:11am

Eledon announce publication fo study evaluating tegoprubart

ELDN

9/6/2023 - 07:16am

Eledon Pharmaceuticals begins dosing in Phase 2 trial of tegoprubart

ELDN

9/5/2023 - 07:15am

Eledon announces dosing of 10th patient in Phase 1b trial of tegoprubart

ELDN

8/16/2023 - 07:12am

Eledon Pharmaceuticals announces upcoming milestones

ELDN

8/10/2023 - 07:02am